Ind-Swift Laboratories receives GMP compliance certificate from NNGYK-Hungary
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
Clinical trial enrollment has long been a bottleneck in drug development
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
The innovation -- UPM Circular Renewable Black -- is the world’s first bio-based, near-infrared (NIR) detectable, carbon-negative black
The Healey ALS Platform Trial is a multicenter, double-blind, placebo-controlled
The product will be marketed by Dr. Reddy's Laboratories Inc.
Subscribe To Our Newsletter & Stay Updated